This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Apr 3;9(5):243-5.

doi: 10.1038/nrurol.2012.59.

Urologic oncology: Poor trial accrual hinders germ cell tumor therapy advances

Michael V Williams, Danish Mazhar

PMID: 22472588
DOI: 10.1038/nrurol.2012.59

Urologic oncology: Poor trial accrual hinders germ cell tumor therapy advances

Michael V Williams et al. Nat Rev Urol. 2012.

. 2012 Apr 3;9(5):243-5.

doi: 10.1038/nrurol.2012.59.

Authors

Michael V Williams, Danish Mazhar

PMID: 22472588
DOI: 10.1038/nrurol.2012.59

No abstract available

PubMed Disclaimer

Similar articles

Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
Vaughn DJ, Stadtmauer EA. Vaughn DJ, et al. J Clin Oncol. 2007 Jan 20;25(3):239-40. doi: 10.1200/JCO.2006.07.6380. J Clin Oncol. 2007. PMID: 17235039 No abstract available.
Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design.
Kourie HR, Aoun F. Kourie HR, et al. Invest New Drugs. 2016 Aug;34(4):513-4. doi: 10.1007/s10637-016-0338-7. Epub 2016 Mar 10. Invest New Drugs. 2016. PMID: 26960332
A review of the management of germ cell tumors: evolution of a curative treatment program.
Iannotti NI, Bosl GJ. Iannotti NI, et al. Cancer Invest. 1990;8(2):173-9. doi: 10.3109/07357909009017563. Cancer Invest. 1990. PMID: 2169330 Review. No abstract available.
The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
Stoter G, Denis L. Stoter G, et al. Acta Urol Belg. 1985;53(2):428-40. Acta Urol Belg. 1985. PMID: 2409785 Review. English, French. No abstract available.
Chemotherapy for clinical stage I nonseminomatous germ cell tumours.
Vaughn DJ. Vaughn DJ. BJU Int. 2009 Nov;104(9 Pt B):1381-6. doi: 10.1111/j.1464-410X.2009.08863.x. BJU Int. 2009. PMID: 19840017 Review. No abstract available.

See all similar articles

Cited by

Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification.
Fontes-Sousa M, Lobo J, Magalhães H, Cassis J, Malheiro M, Ramos S, Henrique R, Martins A, Maurício MJ. Fontes-Sousa M, et al. BMC Urol. 2020 Aug 20;20(1):127. doi: 10.1186/s12894-020-00682-7. BMC Urol. 2020. PMID: 32819326 Free PMC article.
Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey.
Ellis SD, Vaidya R, Unger JM, Stratton K, Gills J, Van Veldhuizen P, Mederos E, Dressler EV, Hudson MF, Kamen C, Neuman HB, Kazak AE, Carlos RC, Weaver KE. Ellis SD, et al. Contemp Clin Trials Commun. 2022 Aug 14;29:100981. doi: 10.1016/j.conctc.2022.100981. eCollection 2022 Oct. Contemp Clin Trials Commun. 2022. PMID: 36033360 Free PMC article.

References

1. Eur J Cancer. 2012 Feb;48(3):385-8 - PubMed
1. J Natl Cancer Inst. 1999 May 19;91(10):839-46 - PubMed
1. J Clin Oncol. 2012 Mar 10;30(8):792-9 - PubMed
1. N Engl J Med. 1987 Jun 4;316(23):1435-40 - PubMed
1. Br J Cancer. 2005 Nov 28;93(11):1209-14 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information